NO20090079L - Arylsulfonamider med analgesisk virkning - Google Patents
Arylsulfonamider med analgesisk virkningInfo
- Publication number
- NO20090079L NO20090079L NO20090079A NO20090079A NO20090079L NO 20090079 L NO20090079 L NO 20090079L NO 20090079 A NO20090079 A NO 20090079A NO 20090079 A NO20090079 A NO 20090079A NO 20090079 L NO20090079 L NO 20090079L
- Authority
- NO
- Norway
- Prior art keywords
- arylsulfonamides
- analgesic effect
- analgesic
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006039003A DE102006039003A1 (de) | 2006-08-19 | 2006-08-19 | Neue Verbindungen |
PCT/EP2007/058408 WO2008022945A1 (de) | 2006-08-19 | 2007-08-14 | Arylsulfonamide mit analgetischer wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090079L true NO20090079L (no) | 2009-02-16 |
Family
ID=38925625
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090079A NO20090079L (no) | 2006-08-19 | 2009-01-07 | Arylsulfonamider med analgesisk virkning |
NO20091025A NO20091025L (no) | 2006-08-19 | 2009-03-09 | Arylsulfonamider med analgesisk virkning |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091025A NO20091025L (no) | 2006-08-19 | 2009-03-09 | Arylsulfonamider med analgesisk virkning |
Country Status (20)
Country | Link |
---|---|
US (2) | US7858618B2 (no) |
EP (3) | EP2402329B1 (no) |
JP (3) | JP5291623B2 (no) |
KR (1) | KR20090047535A (no) |
CN (1) | CN101516867A (no) |
AR (1) | AR062426A1 (no) |
AU (1) | AU2007287652A1 (no) |
BR (1) | BRPI0715645A2 (no) |
CA (1) | CA2663598A1 (no) |
CL (1) | CL2007002407A1 (no) |
CO (1) | CO6160230A2 (no) |
DE (1) | DE102006039003A1 (no) |
EA (1) | EA200900279A1 (no) |
IL (1) | IL197021A0 (no) |
MX (1) | MX2009001791A (no) |
NO (2) | NO20090079L (no) |
SG (3) | SG169337A1 (no) |
TW (1) | TW200815394A (no) |
WO (1) | WO2008022945A1 (no) |
ZA (1) | ZA200810782B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006039003A1 (de) | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
DE102007034620A1 (de) * | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
EP2025675A1 (de) | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
EP2240458B1 (de) * | 2008-02-06 | 2011-08-03 | Boehringer Ingelheim International GmbH | Arylsulfonamide wirksam als schmerzmittel |
EP2262792A1 (de) | 2008-04-08 | 2010-12-22 | Grünenthal GmbH | Substituierte sulfonamid-derivate |
EP2300466B1 (en) | 2008-06-20 | 2014-08-06 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
EP2326625A1 (en) * | 2008-07-18 | 2011-06-01 | Takeda Pharmaceutical Company Limited | Benzazepine derivatives and their use as hstamine h3 antagonists |
US20110301350A1 (en) * | 2008-08-12 | 2011-12-08 | Boehringer Ingelheim International Gmbh | Process for preparing cycloalkyl-substituted piperazine compounds |
US8207335B2 (en) * | 2009-02-13 | 2012-06-26 | Boehringer Ingelheim International Gmbh | Process for making certain compounds having B1 antagonistic activity |
WO2012037119A2 (en) * | 2010-09-13 | 2012-03-22 | Microbiotix, Inc. | Inhibitors of viral entry into mammalian cells |
WO2014009319A1 (en) | 2012-07-11 | 2014-01-16 | Boehringer Ingelheim International Gmbh | Indolinone derivatives anticancer compounds |
KR101735705B1 (ko) | 2015-09-22 | 2017-05-15 | 주식회사 에코시안 | 건물 에너지 효율화 평가 방법 및 장치 |
CN105153168A (zh) * | 2015-09-29 | 2015-12-16 | 上海天慈国际药业有限公司 | N-[4-(2-甲基-4,5-二氢-3H-咪唑并[4,5-d][1]苯并氮杂卓-6-甲酰基)苯基]-2-苯基苯甲酰胺盐酸盐的制备方法 |
KR101645157B1 (ko) | 2015-11-10 | 2016-08-02 | 주식회사 넥스미디어 | 통합 음식 제공 서비스 방법 및 장치 |
WO2019058393A1 (en) | 2017-09-22 | 2019-03-28 | Jubilant Biosys Limited | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD |
CA3076476A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
DK3704120T3 (da) | 2017-11-24 | 2024-05-21 | Jubilant Episcribe Llc | Heterocykliske forbindelser som prmt5-inhibitorer |
JP7279063B6 (ja) | 2018-03-13 | 2024-02-15 | ジュビラント プローデル エルエルシー | Pd1/pd-l1相互作用/活性化の阻害剤としての二環式化合物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1100635B (de) | 1958-04-22 | 1961-03-02 | Rhone Poulenc Sa | Verfahren zur Herstellung von Phenthiazinderivaten |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
WO2001037826A1 (fr) | 1999-11-26 | 2001-05-31 | Shionogi & Co., Ltd. | Antagonistes npyy5 |
FR2819254B1 (fr) * | 2001-01-08 | 2003-04-18 | Fournier Lab Sa | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques |
FR2840897B1 (fr) | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
JP2006516132A (ja) | 2002-12-19 | 2006-06-22 | エラン ファーマシューティカルズ,インコーポレイテッド | 置換n−フェニルスルホンアミドブラジキニン拮抗薬 |
EP1606288B1 (fr) | 2003-03-25 | 2009-06-03 | Laboratoires Fournier Sa | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation pour le traitement de la douleur |
US7557197B2 (en) | 2004-01-28 | 2009-07-07 | Oregon Health & Science University | Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
US7521457B2 (en) | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
WO2006036664A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
WO2006035967A1 (en) | 2004-09-30 | 2006-04-06 | Taisho Pharmaceutical Co., Ltd. | Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
DE102005013967A1 (de) | 2004-11-05 | 2006-10-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
US20060217362A1 (en) | 2004-12-29 | 2006-09-28 | Tung Jay S | Novel compounds useful for bradykinin B1 receptor antagonism |
DE102006039003A1 (de) | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
EP2155689B1 (en) | 2007-05-31 | 2015-07-08 | Boehringer Ingelheim International GmbH | Ccr2 receptor antagonists and uses thereof |
DE102007034620A1 (de) | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
ATE502918T1 (de) | 2007-08-14 | 2011-04-15 | Boehringer Ingelheim Int | Arylsulfonamide mit analgetischer wirkung |
KR20100055469A (ko) | 2007-08-14 | 2010-05-26 | 베링거 인겔하임 인터내셔날 게엠베하 | 신규 화합물 |
DE102007046887A1 (de) | 2007-09-28 | 2009-04-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von (1R,5S)-Anhydroecgoninestersalzen |
-
2006
- 2006-08-19 DE DE102006039003A patent/DE102006039003A1/de not_active Withdrawn
-
2007
- 2007-08-14 CA CA002663598A patent/CA2663598A1/en not_active Abandoned
- 2007-08-14 SG SG201100466-0A patent/SG169337A1/en unknown
- 2007-08-14 KR KR1020097005665A patent/KR20090047535A/ko not_active Application Discontinuation
- 2007-08-14 MX MX2009001791A patent/MX2009001791A/es not_active Application Discontinuation
- 2007-08-14 SG SG201100468-6A patent/SG169339A1/en unknown
- 2007-08-14 JP JP2009525021A patent/JP5291623B2/ja active Active
- 2007-08-14 AU AU2007287652A patent/AU2007287652A1/en not_active Abandoned
- 2007-08-14 EP EP11176839.6A patent/EP2402329B1/de active Active
- 2007-08-14 SG SG201100467-8A patent/SG169338A1/en unknown
- 2007-08-14 WO PCT/EP2007/058408 patent/WO2008022945A1/de active Application Filing
- 2007-08-14 CN CNA2007800345486A patent/CN101516867A/zh active Pending
- 2007-08-14 EP EP07788420.3A patent/EP2061779B1/de active Active
- 2007-08-14 BR BRPI0715645-6A patent/BRPI0715645A2/pt not_active IP Right Cessation
- 2007-08-14 EA EA200900279A patent/EA200900279A1/ru unknown
- 2007-08-14 EP EP10178252.2A patent/EP2284166B1/de active Active
- 2007-08-17 TW TW096130620A patent/TW200815394A/zh unknown
- 2007-08-17 US US11/840,395 patent/US7858618B2/en active Active
- 2007-08-17 CL CL2007002407A patent/CL2007002407A1/es unknown
- 2007-08-17 AR ARP070103674A patent/AR062426A1/es not_active Application Discontinuation
-
2008
- 2008-12-22 ZA ZA200810782A patent/ZA200810782B/xx unknown
-
2009
- 2009-01-07 NO NO20090079A patent/NO20090079L/no unknown
- 2009-02-12 IL IL197021A patent/IL197021A0/en unknown
- 2009-02-19 CO CO09016433A patent/CO6160230A2/es unknown
- 2009-03-09 NO NO20091025A patent/NO20091025L/no not_active Application Discontinuation
-
2010
- 2010-10-05 US US12/898,295 patent/US8252785B2/en active Active
-
2012
- 2012-04-10 JP JP2012089586A patent/JP5529202B2/ja active Active
-
2013
- 2013-04-03 JP JP2013078105A patent/JP5650781B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090079L (no) | Arylsulfonamider med analgesisk virkning | |
DK1986650T3 (da) | Manipulationssikre doserignsformer | |
EP2087096A4 (en) | MODIFIED CYANOBACTERIA | |
DE602007012130D1 (de) | Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase | |
ATE475662T1 (de) | Dihydropyrazolopyrimidinonderivate | |
DE602006004717D1 (de) | Kapselperforationsmodul | |
ATE483711T1 (de) | Spiroindolinonderivate | |
ATE469905T1 (de) | Pyridopyrimidinonderivate | |
ATE512135T1 (de) | Spiroindolinonderivate | |
AT504580A3 (de) | Scan-einrichtung | |
DK2035394T3 (da) | 2-pyrazincarboxamidderivater | |
DE602006019150D1 (de) | Riemenscheibenanorndung | |
ATE546437T1 (de) | Aminomethyl-4-imidazole | |
DK2035369T3 (da) | Terapeutiske | |
DE502007000218D1 (de) | nsetzungen | |
DE502007002453D1 (de) | Kunstoffverdichtergehäuse | |
DE502007001629D1 (de) | Rfahren | |
DE502006006067D1 (de) | Ng | |
DE602006016174D1 (de) | Blisterverpackungsverfahren | |
ATE544764T1 (de) | 5-hydroxymethyloxazolidin-2-onderivate | |
DE502007000361D1 (de) | Stanznieteinheit | |
DE102006045567A8 (de) | Crimpstabilisierung | |
DE112007003147A5 (de) | Rohr-Biegevorrichtung | |
DE502007001652D1 (de) | Notöltank | |
DE502007005975D1 (de) | Wischblatt |